Quantcast

Latest Biomedical Research Council Stories

2014-02-13 00:20:12

The collaboration with Sanofi Pasteur aims to study the loss of immunity and consequent reduced responsiveness to vaccination in elderly.Singapore, Feb 13, 2014 - (ACN Newswire) - A*STAR's Singapore Immunology Network (SIgN) signed a three-year partnership with the National University of Singapore (NUS), National University Hospital (NUH) and Sanofi Pasteur to embark on a Phase IV clinical trial to understand age-related loss of immunity, known as immunosenescence, in elderly.Declining birth...

2013-12-05 12:20:01

This unusual discovery could aid cardiac repair and provide new therapies to common heart diseases and hypertensionSingapore, Dec 6, 2013 - (ACN Newswire) - Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids...

2013-12-02 00:20:07

First EMBO workshop in Singapore marks new milestone in Singapore-Europe cooperation in life sciencesSingapore, Dec 2, 2013 - (ACN Newswire) - A*STAR's Singapore Immunology Network (SIgN) will host Singapore's inaugural European Molecular Biology Organisation (EMBO) workshop on Complex Systems in Immunology from 2nd to 4th December 2013. The 3-day event will bring together researchers from Europe and Singapore to discuss and share the latest insights in...

2013-04-05 00:20:07

National Foundation for Cancer Research (NFCR) honours Professor Alex Matter with esteemed award for groundbreaking cancer pill that gives leukaemia patients a new lease of life.Singapore, Apr 5, 2013 - (ACN Newswire) - Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development...

2012-11-09 14:20:01

- Stratified medicine programme: deliver the right therapy to the right patient at the right time- Eye research: new clinical therapies to cure major eye diseases like glaucoma, corneal disease.Singapore, Nov 9, 2012 - (ACN Newswire) - Singapore announces 8 biomedical sciences research programmes to advance understanding and treatment of diseases especially prevalent amongst the Asian population. These programmes will see biomedical scientists and clinicians working collaboratively to bring...

2012-11-06 06:20:06

Singapore, Nov 6, 2012 - (ACN Newswire) - In a latest boost to A*STAR's collaborations with the industry, Dr Bing LIM, Associate Director of Cancer Stem Cell Biology, and Senior Group Leader at the Genome Institute of Singapore (GIS), was recently awarded a GlaxoSmithKline (GSK) grant under the Academic Centre of Excellence(1) (ACE) to further his research on lung cancer at the GIS.This partnership between GIS and GSK, a multinational pharmaceutical, biologics, vaccines and consumer...

2012-07-19 08:20:01

Singapore, July 19, 2012 - (ACN Newswire) - Professor Paola Castagnoli, Scientific Director of A*STAR's Singapore Immunology Network (SIgN) has been conferred the honour of the "Order of the Star of Italy" (Ufficiale dell'Ordine della Stella d'Italia). This is one of the highest civil honoursawarded by the President of the Italian Republic to Italians overseas and foreigners who have made outstanding contributions to the preservation and promotion of Italy's national prestige abroad. For her...

2012-07-16 04:20:06

Singapore, July 16, 2012 - (ACN Newswire) - Scientists at A*STAR's Singapore Immunology Network (SIgN), in collaboration with Newcastle University, UK, the Singapore Institute of Clinical Sciences and clinicians from multiple hospitals in Singapore, have identified a new subset of dendritic cells (DCs) in human peripheral tissue which have a critical role in activating our immune response against harmful pathogens. This research will have significant impact on the design of vaccines and other...

2012-07-04 04:20:03

Singapore, July 4, 2012 - (ACN Newswire) - A*STAR scientists from the Institute of Molecular and Cell Biology (IMCB) and the Singapore Bioimaging Consortium (SBIC) have discovered a new signalling pathway that controls both obesity and atherosclerosis. The team demonstrated, for the first time, that mice deficient in the Wip1 gene were resistant to weight gain and atherosclerosis via regulation of the Ataxia telangiectasia mutated gene (ATM) and its downstream signalling molecule mTor. These...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'